Application of chitosan–alginate microspheres for the sustained release of bacteriophage in simulated gastrointestinal conditions

This study was designed to evaluate the acid stability, release property and antimicrobial efficacy of Escherichia coli O157:H7 bacteriophages encapsulated in chitosan–alginate microspheres under the simulated gastrointestinal conditions. The bacteriophages belonging to Myoviridae family were stable at the pH above 4 in trypticase soy broth. The chitosan–alginate microspheres exhibited protective effect on the viability of bacteriophages in the simulated gastric conditions at pH 2.0 and pH 2.5, showing 4.8 and 5.6 log PFU mL^‐1, respectively, after 1 h of incubation at 37 °C. The release per cent of bacteriophages from microspheres gradually increased up to 65% in the simulated intestinal condition (pH 7.5) at 37 °C for 6 h. The lytic efficacy of chitosan‐ and alginate‐encapsulated bacteriophages against E. coli O157:H7 was significantly maintained in the simulated intestinal conditions to 10 h of incubation (1.3 log reduction). The results suggest that the chitosan–alginate microspheres can be used as a reliable delivery system for bacteriophages.     

Synthesis of amphiphilic magnetic microspheres by dispersion copolymerization of styrene and poly(ethylene oxide) macromonomer

Amphiphilic magnetic microspheres ranging in diameter from 5 to 100 µm were prepared by dispersion copolymerization of styrene and poly(ethylene oxide) vinylbenzyl (PEO‐VB) macromonomer (MPEO) in the presence of Fe₃O₄ magnetic fluid. The effects of various polymerization parameters on the average particle size were systematically investigated. The average particle size was found to increase with increasing styrene concentration and initiator concentration. It also increased with decreasing stabilizer concentration and molecular weight of MPEO. The content of the hydroxyl groups localized in the microspheres ranged from 0.01 to 0.2 mmol g^?1. © 2003 Society of Chemical Industry     

Preparation of monodisperse poly(vinyl alcohol) microspheres by heterogeneous surface saponification and iodine complex formation

Monodisperse poly(vinyl acetate) (PVAc) microspheres with high molecular weight obtained by suspension polymerization of vinyl acetate were saponified in alkaline aqueous solution to keep their spherical structure. The saponification was restricted on the surface of the PVAc microspheres and obtained particles had skin/core structure. Various poly(vinyl alcohol) (PVA) microspheres with different diameters and degrees of saponification (DSs) were obtained. The conversion of PVAc to PVA during the heterogeneous surface saponification time were examined by nuclear magnetic resonance spectroscopy and after 72 h hydrogel type PVA microspheres completely saponified were obtained. The crystal melting temperatures of the microspheres obtained by the saponification were measured a constant value of 238°C irrespective of varying DS, and the peaks became enlarged as reaction time. Iodine complexes were formed in saponified microspheres with DS of 41% and 99% by immersing them in I₂/KI aqueous solution and decomposed by the reduction of I₂ in the complexes to 2I^? using sodium sulfite to confirm whether the skin formed through the saponification was composed of PVA with high VA content. Obviously, characteristic blue color developments owing to I₅^?‐PVA complexes were observed in both saponified regions and a red in the PVAc core. Consequently, it was concluded that the PVA skins formed by heterogeneous surface saponification had high DSs. Such complexes endowed polymeric microspheres a good radiopacity which would be useful in clinical treatment of vascular diseases and were examined by X‐ray irradiation image. © 2007 Wiley Periodicals, Inc. J Appl Polym Sci, 2008     

多表位DNA壳聚糖微球疫苗的体液免疫应答

目的研究多表位DNA壳聚糖微球疫苗的体液免疫应答。方法制备多表位DNA壳聚糖微球疫苗pcD-NA3.1-HME-3C3d,经鼻腔免疫小鼠,蛋白检测微孔试剂盒检测小鼠特异性IgG抗体水平。结果经免疫的小鼠均能产生针对各表位的特异性IgG抗体,DNA壳聚糖微球疫苗的抗体水平明显高于DNA疫苗。结论壳聚糖微球疫苗投递系统可提高多表位DNA疫苗的免疫应答效果。     

两亲性聚合物多孔微球的制备研究

合成了具有悬挂双键的苯乙烯-二乙烯基苯多孔微球,在悬挂双键处接枝甲基丙烯酸甲酯,制成了一系列不同接枝度的两亲性聚合物多孔微球。考察了悬挂双键数量、反应时间等因素对接枝率的影响以及接枝率对微球形貌的影响。实验中通过观测澄清点,有效地控制了反应后期自加速现象对接枝率的影响。在反应时间25 m in时,制得了平均孔径为50 nm的两亲性多孔微球。将该微球用于对化妆品活性组分的负载,对极性物的负载率比接枝前高出2倍。     

阿司匹林聚乳酸／SiO2微球的制备及其体外缓释研究

应用自制的聚乳酸／SiO2材料为药物载体通过溶剂挥发法制备了阿司匹林微球，并对该微球的粒径、包封率、载药量以及体外缓释性能进行了研究。微球电镜图片显示粒径大小分布在15μm左右，符合缓释制剂要求。体外缓释研究所得Higuchi方程为Q=0．3598＋0．03t^1/2，相关系数P=0．9961，该结果显示所得微球具有明显缓释作用。     

聚乳酸-聚氨酯微球的合成及其形态的研究

以低相对分子质量生物可降解D，L-聚乳酸(D，L-PLA)二醇和六亚甲基二异氰酸酯(HDI)为原料、1，4-丁二醇(BD)为扩链剂及聚乙烯基吡咯烷酮(PVP)为悬浮剂，通过悬浮聚合法初步合成了一种新型聚氨酯微球(PUMS)。用扫描电子显微镜(SEM)考察了BD的含量对微球表面形态的影响，通过激光粒度分析仪讨论了搅拌速率和PVP浓度对微球粒径及其分布的影响，用傅立叶变换红外光谱(FTIR)粒度分析仪对微球的化学结构进行了表征。结果表明，合成的微球的平均粒径随搅拌速率和PVP浓度的增加而减少，粒径分布变宽；当搅拌速率为400r／min，PVP质量分数为1．5％时。微球的平均粒径约47μm，粒径分布最窄。约在10～90μm；微球表面有孔，但随着BD含量的增加，微球表面变得相对粗糙，孔数减少，孔径减小，直至孔消失。     

中空聚合物微球的制备Ⅲ.种子扩径的影响

以预乳化液连续滴加进料的三段乳液聚合结合碱酸溶胀处理制备了单分散性良好、大粒径的聚(甲基丙烯酸-甲基丙烯酸甲酯-丙烯酸丁酯)/聚(甲基丙烯酸-苯乙烯)中空聚合物微球。实验发现,在二段乳液聚合种子扩径中,种子乳胶粒数目、乳化剂用量、预乳化液滴加时间等对避免新乳胶粒的生成、扩大种子乳胶粒的粒径有影响,并找到了各自的较优值;扩径单体中的丙烯酸丁酯含量显著影响扩径乳胶粒聚合物的玻璃化温度,进而决定碱酸处理温度。     

粘度调节剂对制备环氧树脂微球的影响

研究粘度调节剂对环氧树脂/二氨基二苯基砜/聚醚酰亚胺(EP/DDS/PEI)共混物相结构及制备EP微球的影响。结果表明,共混物中加入粘度调节剂后,固化过程中共混体系的粘度明显降低,随着粘度调节剂用量的增加,EP分散相尺寸逐渐增大,制得的EP微球粒径及粒径分布指数逐渐增大。EP微球的红外光谱显示粘度调节剂对EP微球的成分和相结构没有明显影响。     

Environmentally benign precipitation copolymerization of methacrylate ester and styrene to make polymeric microspheres in supercritical carbon dioxide

The polymeric microspheres were synthesized by the precipitation copolymerization of glycidyl methacrylate (GMA) with methacrylic acid(MAA) or 2‐hydoxyethyl methacrylate (2‐HEMA) containing styrene (ST) in SC‐CO₂. Scanning electron microscopy (SEM) showed that the products were spherical microparticles, with the addition of MAA and/or 2‐HEMA as the monomer, with diameter of 0.2–2 μm. The effects of copolymerization pressure, temperature, and ratios of GMA/MAA, ST, and/or GMA/2‐HEMA, on the particle size and morphology were investigated in detail. A new experiment setup is proposed for the large amount of production, based on the rule of lower monomer concentration, more stable system, and better use of the present polymerization apparatus. © 2006 Wiley Periodicals, Inc. J Appl Polym Sci 103: 2425–2431, 2007